New Injected Medication Delivery Systems for Better Control
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
This project aims to create advanced injectable systems that deliver medications more effectively and for longer periods, helping people with acute or chronic conditions take their medicines as prescribed.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rice University NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11144347 on NIH RePORTER |
What this research studies
Many people take daily medications for various health issues, but it can be hard to remember doses or deal with frequent injections. This project is working on new ways to deliver medicines through injections that release the drug slowly over time. By using special biodegradable materials, these systems could ensure the right amount of medicine is in your body when needed, reducing how often you need a shot. This could make it easier to stick to your treatment plan and improve how well your medications work.
Who could benefit from this research
Good fit: Patients who currently take medications for acute or chronic conditions, especially those requiring frequent doses or injections, could potentially benefit from future applications of this research.
Not a fit: Patients whose conditions are not treated with injectable medications or who do not struggle with medication adherence may not directly benefit from this specific drug delivery approach.
Why it matters
Potential benefit: If successful, this work could lead to new injectable medications that are more convenient, improve patient adherence, and provide more consistent drug levels for people with acute or chronic conditions.
How similar studies have performed: While current controlled-release systems exist, this project seeks to overcome their limitations by developing novel materials and methods for broader drug types and improved release profiles.
Where this research is happening
Houston, United States
- Rice University — Houston, United States (Active)
Researchers
- Principal investigator: Mchugh, Kevin James — Rice University
- Study coordinator: Mchugh, Kevin James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.